Significance of the optimized S1 / S2 restriction site for SARS-CoV-2 infection (SARS_S1S2)

  • Funded by Bundesministerium für Bildung und Forschung [German Federal Ministry of Education and Research] (BMBF)
  • Total publications:8 publications

Grant number: 01KI20396

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2021
  • Known Financial Commitments (USD)

    $58,159.53
  • Funder

    Bundesministerium für Bildung und Forschung [German Federal Ministry of Education and Research] (BMBF)
  • Principal Investigator

    Prof Dr Stefan Pöhlmann
  • Research Location

    Germany
  • Lead Research Institution

    Deutsches Primatenzentrum Gesellschaft mit beschränkter Haftung- Leibniz-Institut für Primatenforschung
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen morphology, shedding & natural history

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

As part of the already funded coronavirus project (BMBF-Verbund RAPID: Risk assessment in prepandemic respiratory infectious diseases, subproject 4: Efficiency of the proteolytic activation of respiratory viruses as a marker for pandemic potential), it is investigated whether naturally occurring MERS-CoV variants represent an increased pandemic Show potential. A virus variant was identified in patients in Saudi Arabia that carries the T746K exchange at the S1 / S2 interface of the viral spike protein (S). This exchange leads to the fact that the cleavage of the S protein at the S1 / S2 interface is intensified by the cellular protease furin in infected cells. Also increased the exchange of virus entry into lung cells, which depends on the activation of the S protein by the cellular protease TMPRSS2. Finally, the exchange increases the resistance to the interferon-induced host cell factors GBP2 and GBP5. To what extent T746K increases the virus spread in primary lung epithelium in vitro and the viral spread and pathogenesis in experimentally infected marmosets is unclear and is being investigated in the ongoing project.

Publicationslinked via Europe PMC

Efficient antibody evasion but reduced ACE2 binding by the emerging SARS-CoV-2 variant B.1.640.2.

Investigations on SARS-CoV-2 Susceptibility of Domestic and Wild Animals Using Primary Cell Culture Models Derived from the Upper and Lower Respiratory Tract.

Evidence for an ACE2-Independent Entry Pathway That Can Protect from Neutralization by an Antibody Used for COVID-19 Therapy.

No evidence for increased cell entry or antibody evasion by Delta sublineage AY.4.2.

Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccination.

The Upper Respiratory Tract of Felids Is Highly Susceptible to SARS-CoV-2 Infection.

SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination.

Inhibition of acid sphingomyelinase by ambroxol prevents SARS-CoV-2 entry into epithelial cells.